LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
China flag China · Delayed Price · Currency is CNY
8.52
+0.34 (4.16%)
Aug 20, 2026, 3:04 PM CST

SHE:002644 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
926.49915.53980.231,1631,042817.64
Revenue Growth
1.73%-6.60%-15.73%11.58%27.49%22.39%
Gross Profit
309.79308.81298.76358.96304.16221.07
Operating Income
78.7569.4743.5562.966.145.65
Net Income
58.8449.2160.0767.19108.6593.26
Earnings Per Share
0.120.100.120.130.210.18
EPS Growth
8.79%-18.03%-10.64%-38.16%16.54%-13.66%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Pharmaceutical Industry
912.36978.121,1611,009798.52
Food Industry
3.172.111.81.6611.94
Total
915.53980.231,1631,042817.64

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
634.61524.49397.89406.04399.85374.94
Total Debt
31.845.4940.7952.6355.668.65
Net Cash (Debt)
602.82479357.1353.41344.26306.29
Net Cash Growth
69.72%34.13%1.04%2.66%12.39%-12.86%
Net Cash Per Share
1.180.940.700.690.670.60

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
326.43183.9538.9865.7186.6111.85
Capital Expenditures
-33.81-18.55-13.29-22.47-41.53-32.81
Free Cash Flow
292.62165.425.743.2445.08-20.95
Free Cash Flow Growth
516.29%543.70%-40.58%-4.08%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
33.44%33.73%30.48%30.86%29.18%27.04%
Operating Margin
8.50%7.59%4.44%5.41%6.34%5.58%
Pretax Margin
8.07%7.10%7.05%7.02%12.54%13.55%
Profit Margin
6.35%5.38%6.13%5.78%10.42%11.41%
FCF Margin
31.58%18.07%2.62%3.72%4.32%-2.56%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.0200.0200.0120.0300.0500.010
Dividend Per Share Growth
66.67%66.67%-60.00%-40.00%400.00%-91.67%
Dividend Yield
0.24%0.23%0.16%0.31%0.54%0.10%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
73.9589.6665.6374.1043.8554.98
Forward PE
-53.8853.8853.8853.8853.88
P/FCF Ratio
14.8726.68153.42115.14105.68-
PS Ratio
4.704.824.024.284.576.27